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Abstract
Background: Vernal keratoconjunctivitis (VKC) is a severe ocular allergy with
pathogenic mechanism poorly understood and no efficacious treatment. The aims
of the study were to determine quantities and distribution of Hsp chaperones in
the conjunctiva of VKC patients and assess their levels in conjunctival epithelial
and fibroblast cultures exposed to inflammatory stimuli.
Methods: Hsp10, Hsp27, Hsp40, Hsp60, Hsp70, Hsp90, Hsp105, and Hsp110
were determined in conjunctiva biopsies from nine patients and nine healthy age-
matched normal subjects, using immunomorphology and qPCR. Conjunctival
epithelial cells and fibroblasts were cultured and stimulated with IL-1b, histamine,
IL-4, TNF-a, or UV-B irradiation, and changes in Hsp levels were determined by
Western blotting.
Results: Hsp27, Hsp40, Hsp70, and Hsp90 levels increased in the patients’ con-
junctiva, whereas Hsp10, Hsp60, Hsp100, and Hsp105 did not. Double
immunofluorescence demonstrated colocalization of Hsp27, Hsp40, Hsp70, and
Hsp90 with CD68 and tryptase. Testing of cultured conjunctival cells revealed an
increase in the levels of Hsp27 in fibroblasts stimulated with IL-4; Hsp40 in
epithelial cells stimulated with IL-4 and TNF-a and in fibroblasts stimulated with
IL-4, TNF-a, and IL-1b; Hsp70 in epithelial cells stimulated with histamine and
IL-4; and Hsp90 in fibroblasts stimulated with IL-1b, TNF-a, and IL-4. UV-B
did not induce changes.
Conclusions: VKC conjunctiva displays distinctive quantitative patterns of Hsps
as compared with healthy controls. Cultured conjunctival cells respond to cytoki-
nes and inflammatory stimuli with changes in the Hsps quantitative patterns. The
data suggest that interaction between the chaperoning and the immune systems
drives disease progression.
Vernal keratoconjunctivitis (VKC) is a severe, rare, chronic
ocular allergy affecting mostly children and adolescents living
in warm climates (1). Even though it tends to resolve at
puberty, VKC affects the quality of life of patients and their
parents. It is an IgE- and T cell-mediated allergic reaction
with additional, ill-defined, nonspecific hypersensitivity
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responses (2). Only 50% of VKC patients are positive to skin
prick test and serum specific IgE. As in other atopic diseases,
such as atopic dermatitis and asthma, the specific trigger
remains elusive in most cases. A variety of nonspecific fac-
tors, including hot climate, sun light, dry wind, ultraviolet
(UV)-B exposure, oxidative stress, and possible panallergens,
exacerbate or perpetuate the ocular inflammation. In addi-
tion to typical Th2-derived cytokines, Th1-type cytokines,
chemokines, growth factors, and enzymes are augmented in
VKC patients (3, 4).
Conjunctival fibroblasts and epithelial cells activities and
phenotypes in vitro can be modulated by diverse mediators
involved in the ocular allergic reaction, such as histamine,
IL-4, TGF-b1, and TNF-a (4–8), and by UV-B (9). Tissue
remodeling reactions, stem cell deficiency, and various
degrees of superficial corneal ulcers and scars are further con-
sequences of chronic inflammation. Also, possible complica-
tions such as cataract and glaucoma due to prolonged topical
treatment with corticosteroids can occur. Therefore, the risk
of visual impairment in VKC is a real threat (10). Despite
the fact that nowadays there is considerable evidence of par-
ticipation of Hsp chaperones in inflammatory and autoim-
mune conditions and of interaction of the immune and
chaperoning systems (11, 12), no studies have addressed these
issues pertaining VKC.
Hsp chaperones designate a large group of molecules of
which many are the products of heat shock genes (i.e., genes
inducible by stressors), play various roles in protein home-
ostasis, and form part of the chaperoning system (11–14).
Chaperones have been implicated in the pathogenesis of vari-
ous diseases such as some types of cancer and inflammatory
and autoimmune disorders (11, 12, 15, 16). Key questions
still unanswered are: Do Hsps change quantitatively in VKC,
suggesting their participation in pathogenesis and/or cytopro-
tection? Are Hsp levels affected by agents known to initiate
or aggravate VKC, such as histamine and UV-B? The aims
of this study were to determine the levels and distribution of
Hsps in VKC-affected tissue and to assess the effect of
cytokines and other factors known to be involved in VKC
pathogenesis on the levels of Hsps in cultured conjunctiva
cells.
Materials and methods
Conjunctiva biopsies
Conjunctival tissues from nine active VKC patients (7 males
and 2 females; mean age 10.4  3.6) and nine healthy age-
matched normal subjects (controls) were studied. The control
group included six males and three females (mean age
12.0  5) who underwent eye surgery. None of these control
subjects used contact lenses or had inflammatory signs and
symptoms or history of allergy. Diagnosis of VKC was based
on the typical clinical history and evaluation of signs and
symptoms. All VKC patients were free of topical antiallergic
drugs for at least 3 days and topical corticosteroids for at
least 7 days before sample collection. Six VKC patients were
positive to serum specific IgE for at least one pollen. In all
VKC patients, a clinical activity score (0–4) was given consid-
ering the overall severity of the disease at the time of sample
collection (1, 2).
Upper tarsal conjunctival biopsies were snap-frozen with
or without optimal cutting temperature (OCT) compound
(Histo-Line Laboratories, Pantigliate, MI, Italy) in liquid
nitrogen and maintained at 80°C. This research was
approved by the Institutional Review Board and adhered to
the tenets of the Declaration of Helsinki. A written informed
consent was obtained from all subjects or their parents before
obtaining tissue specimens.
Immunohistochemistry (IHC)
Serial 5-lm-thick cryosections were fixed in 4% buffered
formaldehyde and processed for IHC. Antibodies against the
following human Hsps were used: Hsp10, Hsp27, Hsp40,
Hsp60, Hsp70, Hsp90, Hsp105, and Hsp110. All antibodies
were purchased from Santa Cruz Biotechnology (Dallas, TX,
USA), except anti-Hsp110 (BD Biosciences, San Jose, CA,
USA). Primary antibodies were revealed as previously
reported (4). Observation with a light microscope (Leica
Axioplan, Wetzlar, Germany) was performed at a magnifica-
tion of 4009. The positive reaction was evaluated in the
epithelium and subepithelial stroma of conjunctival tissues
and classified as very intense (3+), intense (2+), slight (1+), or
absent (0). All the slides were evaluated by three investigators
following a blind procedure.
Double immunofluorescence
Tissue sections were incubated with unmasking and with
blocking solutions and subsequently incubated with the first
primary antibody (mouse anti-human CD68 or mouse anti-
human tryptase) for 1 h followed by the second primary
antibody (anti-Hsp27, or anti-Hsp40, or anti-Hsp70, or anti-
Hsp90) for another hour. The sections were then washed
twice in phosphate-buffered saline (PBS) and incubated with
goat-IgG antibody conjugated with fluorescein isothiocyanate
and/or mouse-IgG antibody conjugated with Texas Red
(Vector Laboratories, Burlingame, CA, USA) for 1 h at
23°C, and the nuclei were counterstained with Hoechst
(Sigma, San Louis, MO, USA) for 15 min. The tissue was
observed with a Zeiss fluorescence microscopy (Zeiss, Heidel-
berg, Germany) by two independent observers.
RNA isolation and quantitative PCR (qPCR) analysis
Total RNA was extracted from conjunctival tissues by TRI-
zol (Life Technologies, Carlsbad, CA, USA) according to the
manufacturer’s protocol. The RNA concentration of each
sample was quantified using NanoDrop 2000c Spectropho-
tometer (Thermo Scientific, Wilmington, DE, USA). Primers
pairs (Table 1) were designed using the Primer3 Pick primers
from a DNA sequence program and synthesized. Briefly,
1 lg of total RNA was retro-transcribed into cDNA using
oligo(dT)12-18, 25 ng primers and SuperScript II Rev-
erse Transcriptase 200 U (Life Technologies). Quantitative
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RT-PCR analysis was carried with Rotor Gene RG-3000A
Real Time PCR system (Corbett Research, Sydney, Aus-
tralia) using SYBR Green I dye (Roche, Mannheim, Ger-
many) and combined sense and antisense primers at 300 nM
final concentration. The following cycling conditions were
used: initial denaturation step of 10 min at 95°C, 45 cycles of
amplification consisting of 15 s at 95°C, 30 s at 60°C, and
30 s at 72°C. cDNA samples were analyzed in triplicate.
Gene expression was evaluated with the DCt method using
peptidylprolyl isomerase A (PPIA) as reference gene (17).
Cell cultures
Wong–Kilbourne-derived Chang conjunctival (ChWK)
epithelial cells were obtained from ATCC (clone 1-5c-4) and
were grown in Dulbecco’s modified Eagle medium (DMEM)
(Sigma) supplemented with 10% fetal bovine serum (FBS)
(GIBCO, New York, USA) and antibiotics. Fibroblasts were
obtained from upper tarsal conjunctival biopsies of two of
the normal subjects and cultivated in DMEM supplemented
with 10% FBS. Third- to fifth-passage fibroblasts were used
for the experiments.
Epithelial cells and fibroblasts grown on 6-cm-diameter cell
plates (Falcon, Durham, NC) were maintained in serum-free
conditions supplemented with 10 ng/ml of histamine (Sigma)
or 1 ng/ml of human recombinant IL-1b, or 10 ng/ml IL-4,
or TNF-a (Peprotech, London, UK), then detached with
trypsin, washed with PBS, and frozen at 80°C until lysis.
Preliminary data showed that 1 or 10 ng/ml cytokines yielded
the best results for the purposes of this study. UV-B irradia-
tion was performed after 18 h of cell starvation, and then,
PBS was replaced with complete culture medium supple-
mented with 10% FBS for 4, 10, or 24 h and harvested for
cell lysis as described above. Irradiation was carried out with
a central wavelength of 302 nm for 30 min, using a interfer-
ential filter, had a full width half maximum (FWHM) band-
width of 11 nm (from 296 nm up to 307 nm), obtaining a
final dose of 11 mJ/cm2. Three culture wells were used for
each treatment. After 4, 10, or 24 h of exposure, Hsp27,
Hsp40, Hsp70, and Hsp90 levels were determined by Western
blotting.
Western blotting
Conjunctival fibroblasts and epithelial cell pellets were trea-
ted for 45 min at 4°C with RIPA lysis buffer (1% v/v Tri-
ton X-100, 0.5% w/v deoxycholic acid, 10 mM EDTA in
PBS, Sigma) supplemented with protease inhibitor cocktail.
After removing particulate material by centrifugation,
supernatants were collected and protein concentration was
determined using the Bradford Assay. Ten lg of lysates
was separated on 10% polyacrylamide gels and transferred
to nitrocellulose membrane. After blocking nonspecific
binding sites, the nitrocellulose membrane was incubated
with anti-Hsp40 (Novus Biologicals, Cambridge, UK) or
anti-Hsp60, anti-Hsp70, anti-Hsp27, anti-Hsp90 (Santa
Cruz) diluted in TBS, 0.1% Tween-20 (TBST; Tris-buffered
saline and Tween 20, Sigma) for 2 h at 23°C. After three
washes in TBST, the membrane was incubated with horse-
radish peroxidase (HRP)-conjugated anti-mouse-IgG (GE
Healthcare, Buckinghamshire, UK) for Hsp40, or anti-goat-
IgG HRP-conjugated (R&D Systems, Minneapolis, MN,
USA) for the other Hsp. The antibody reaction was
revealed by chemiluminescence using ECL Plus (GE
Healthcare). Blots were sequentially incubated with mono-
clonal anti-b-actin antibody (Sigma) diluted 1:4,000 and
processed as described above. Densitometric values of Hsp-
positive bands were normalized with the corresponding
value of b-actin.
Statistical analysis
Western blotting was performed in triplicate, and the data
are presented as mean  standard error (SEM). Comparison
between groups was made using Student’s unpaired test. The
comparison of Hsp levels in VKC and normal samples was
Table 1 Hsp chaperone genes investigated and primers used
Gene (accession number) Name Primer sequences
HSPB1 (NM_001540) Heat shock 27-kDa protein 1 Fw: 50-CAAGTTTCCTCCTCCCTGTCC-30
Rv: 50-AAGGTGACTGGGATGGTGA-30
DNAJB1 (NM_006145.2) DnaJ (Hsp40) homolog, subfamily B,
member 1, transcript variant 1
Fw: 50-GCCAATGGTACCTCTTTCAGCTAC-30
Rv: 50-CGCTGTAGATCTCTTCAAGGGA-30
HSPA1A (NM_005345) Heat shock 70-kDa protein 1A Fw: 50-AGGGAGGGTCTGGGTCA-30
Rv: 50-GGAAATGCAAAGTCTTGAAGCTCC-30
HSPA1B (NM_005346.4) Heat shock 70-kDa protein 1B Fw: 50-AGGGAGGGTCTGGGTCA-30
Rv: 50-ACAAAGAAGTGAAGCAGCAAAGAG-30
HSP90AA1 (NM_001017963.2) Heat shock protein 90-kDa alpha
(cytosolic), class A member 1
Fw: 50-GGTCTTCCCAGCATGTACTCAG-30
Rv: 50-ACAACGTGGACACTAAGAGAACA-30
HSP90AB1 (NM_007355.2) Heat shock protein 90-kDa alpha
(cytosolic), class B member 1
Fw: 50-ACCGAGCCCATTGACGA-30
Rv: 50-CCTTGCTCTCTTCCATCTTCTTCTTC-30
PPIA (NM_021130.3) Peptidylprolyl isomerase A (cyclophilin A) Fw:-50-GGGCTTTAGGCTGTAGGTCAA-30
Rv: 50-AACCAAAGCTAGGGAGAGGC-30
Fw, forward; Rv, reverse; PPIA, peptidylprolyl isomerase A (housekeeping gene used as control).
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analyzed using the nonparametric Mann–Whitney U-test.
Spearman’s correlation analysis was performed to determine
the relationship between Hsp tissue expression and clinical
severity of the disease. For statistical significance, the thresh-
old P value was P ≤ 0.05.
Results
Examination of biopsies from VKC patients
Tissue levels of the Hsp10, Hsp27, Hsp40, Hsp60, Hsp70,
Hsp90, Hsp105, and Hsp110 were evaluated by immunohis-
tochemistry (IHC; Table 2). In normal and pathological tis-
sues, all proteins were present in the stroma, while Hsp27
and Hsp90 were detected also in the epithelium. VKC speci-
mens showed increased levels of Hsp27, Hsp40, Hsp70, and
Hsp90 in the stroma, compared to controls (Fig. 1). By con-
trast, in VKC epithelium, only Hsp27 levels were significantly
higher than in controls; the levels of the others did not
change significantly. The clinical activity score of the disease
at the time of sample collection was significantly correlated
with stromal expression of Hsp27 (r = 0.66; P = 0.034),
Hsp40 (r = 0.76; P = 0.01), Hsp70 (r = 0.73; P = 0.015), and
Hsp90 (r = 0.88; P = 0.0006).
Double immunofluorescence revealed colocalization of
CD68-positive cells and of some Hsps only in the stroma of
VKC tissues: about 20% of CD68-positive cells were also
positive to Hsp27, 50% to Hsp40, 30% to Hsp70, and 70%
to Hsp90 (Fig. 2A). Tryptase-positive cells colocalized also
with Hsp40 (8% of cells), Hsp70 (10%), and Hsp90 (15%),
but not with Hsp27 (Fig. 2B).
The qPCR analyses, performed only for those Hsps with
increased levels as determined by IHC, did not show changes
in their mRNA levels. This may be due to the fact that
qPCR is performed on biopsy fragments that include the two
mucosa layers (epithelium and stroma), while IHC can detect
the Hsp molecules in situ, in both layers separately providing
information on tissue localization and a measure of Hsp
levels distinctive of each layer.
Effect of immune system products and inducers on
conjunctival Hsps
Only levels of Hsp27, Hsp40, Hsp70, and Hsp90 that showed
changes in vivo were analyzed in conjunctival cell cultures.
Hsp27 levels significantly increased only in fibroblasts after
IL-4 or TNF-a stimulation (Fig. 3A). Hsp40 levels signifi-
cantly increased in fibroblasts after IL-1b, or IL-4, or TNF-a
and in epithelial cells after IL-4 stimulation (Fig. 3B). Hsp70
levels significantly increased only in epithelial cells after his-
tamine, or IL-4 stimulation (Fig. 3C). Hsp90 levels signifi-
cantly increased in fibroblasts after TNF-a, or IL-1b, or IL-4
stimulation (Fig. 3D). UV-B irradiation did not increase the
levels of any Hsp in neither conjunctival cell type tested.
Discussion
In the last two decades, it has been established that chaper-
ones, the main components of the physiological chaperoning
system, interact with the immune system at various levels
and are involved in inflammation and autoimmunity in ways
not yet completely elucidated. Therefore, it is pertinent to
investigate the levels and distribution of Hsps in tissues
affected by inflammatory and allergic-autoimmune diseases
with no satisfactory treatments, such as VKC, to explore new
roads that might lead to the development of novel therapies
using chaperones for cytoprotection and as anti-inflammatory
agents. It would be worthwhile to develop chaperonothera-
pies, positive, that is, promote chaperone function, or nega-
tive, that is, block chaperone effects (12, 18). Before these
studies can be undertaken in VKC, it is necessary to unveil
the quantitative patterns of Hsps in affected tissues and char-
acterize the effects of immune system products on the Hsps
in the conjunctiva.
Understanding VKC pathophysiology and treatment con-
tinues to be a challenging task for ophthalmologists, aller-
gists, and pediatricians because the etiology is unclear and
antiallergic therapies are often unsuccessful. Severe signs and
symptoms in VKC are triggered most frequently by nonspeci-
fic stimuli such as exposure to sun light and high tempera-
tures and partially explained by increased or reduced levels
of proinflammatory (19) and of anti-inflammatory factors
(20), respectively. However, the initial molecular events that
induce the inflammation in VKC and the complexity of fac-
tors that orchestrate and maintain inflammation remain
unclear.
It has been suggested that smaller Hsps (<56 kDa) are
anti-inflammatory and larger ones (>65 kDa) are proinflam-
matory, while Hsp60 (range 56–65 kDa) can be both (21). In
the present study, we found significantly increased levels of
Hsp27, Hsp40, Hsp70, and Hsp90 in VKC conjunctiva com-
pared to controls, mostly in conjunctival stroma and colocal-
ized with CD68 and with tryptase. Both macrophages and
mast cells are abundant in VKC and correlated with the
inflammatory status (22). Interestingly, Hsps found signifi-
cantly increased in VKC tissues were correlated with the clin-
ical severity score of the disease. These results suggest that
Hsps participate in the pathological process as cytoprotective
Table 2 Hsp levels in VKC and controls determined by immunohis-
tochemistry
Hsp chaperone
Conjunctival
stroma
Conjunctival
epithelium
VKC Control VKC Control
Hsp10 +* +/  
Hsp27 ++ +/ +++ +
Hsp40 +++ +/  
Hsp60 +/ +/  
Hsp70 ++ +/  
Hsp90 ++ + ++ +
Hsp105 +/ +/  
Hsp110 +/ +/  
*See text (Materials and Methods, Immunohistochemistry) for
explanation of symbols (reaction intensity).
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or pathogenic, as proposed for other pathologies (23–27).
This may also suggest that a modulation/inhibition of the
overexpressed proinflammatory Hsp70 and Hsp90 may play
a role in reducing the inflammatory burden in VKC. We did
not study the quantitative patterns of Th2 or Th1 cytokines
that might be associated with increased levels of Hsps; how-
ever, a prevalent Th2 pattern of cytokine production, associ-
ated with a Th1 pattern in more severe inflammatory states,
has been reported in VKC (7).
To determine whether immune system products and stimuli
induce Hsps in the conjunctiva and contribute to its inflam-
mation, we exposed conjunctiva epithelial cells and fibrob-
lasts to a panel of agents, including UV-B radiation, that
have been implicated in VKC (3). Histamine, IL-1, IL-4, and
TNF-a increased Hsp levels, while UV-B exposure did not
under our experimental conditions. Noteworthy, the
responses were distinctive of cell and Hsp type (Table 3).
This suggests that the overall response of the two conjuncti-
Figure 1 Hsp immunostaining (in red) in biopsies from VKC con-
junctiva compared to those from healthy controls. Representative
images show increased Hsp27, Hsp40, Hsp70, and Hsp90 levels in
the conjunctiva from VKC patients. Negative controls were prepared
by omitting the primary antibody. Bar: 200 lm.
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val layers to stimuli is delicately coordinated and orches-
trated to produce well-defined sets of Hsps, whose imbal-
ances may drive the course of the disease toward
progression–aggravation or toward stabilization–remission.
We also observed a prevalent induction of lower MW Hsps
(Hsp27 and Hsp40) by IL-4. In contrast, a prevalent induc-
tion of higher MW Hsps (Hsp70 and Hsp90) was observed
after proinflammatory challenges.
In conclusion, our study supports the hypothesis that
Hsp27, Hsp40, Hsp70, and Hsp90 are actively involved in
VKC, while other Hsps such as Hsp10, Hsp60, Hsp105, and
Hsp110 are not, or if they are, they would do so in ways not
detectable with the methods used in this study. Our data
indicate active interaction between the chaperoning and the
immune systems, with perhaps a mutual modulatory role
between the two systems. A delicate balance in this modula-
A
B
Figure 2 (A) Double immunofluorescence revealing colocalization of CD68 (red) with Hsps (green), as indicated, in the conjunctiva from
VKC patients. (B) Double immunofluorescence revealing colocalization of tryptase (red) with various Hsp (green), as indicated, in the conjunc-
tiva from VKC patients. Bar: 100 lm. In the boxes, high magnification of double-staining cells (arrowhead).
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tion can be envisioned that if altered in one direction can
lead to rapid disease progression, or if unbalanced in the
opposite direction can bring about disease stabilization
or even remission. Gene expression and possible gene
modification of the overexpressed Hsps will be further stud-
ied in a larger cohort of VKC patients. The understanding of
the chaperones’ roles in VKC conjunctiva will open new ther-
apeutic scenarios leading, for example, to the use of specific
topical inducers or inhibitors of Hsps (depending on whether
the targeted Hsp is cytoprotective or etiopathogenic), as an
effective chaperonotherapy (18), in turn preventing the severe
complications of this eye disorder.
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